Yuhua Chen Selected Research

Integrins

1/2020	Myofibroblast induces hepatocyte-to-ductal metaplasia via laminin-ɑvβ6 integrin in liver fibrosis.
11/2009	Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
12/2008	An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.
12/2005	Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment.
9/2004	An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats.
4/2004	Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.
3/2004	Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuhua Chen Research Topics

Disease

14	Neoplasms (Cancer) 01/2021 - 11/2002
11	Spinal Cord Injuries (Spinal Cord Injury) 08/2011 - 03/2004
10	Inflammation (Inflammations) 01/2021 - 04/2004
5	Traumatic Brain Injuries (Traumatic Brain Injury) 10/2021 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 04/2018 - 07/2012
5	Neoplasm Metastasis (Metastasis) 06/2017 - 11/2011
4	Neuroinflammatory Diseases 10/2021 - 01/2019
4	Hyperalgesia 02/2009 - 04/2004
3	Infections 04/2022 - 01/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 01/2019
3	Stroke (Strokes) 01/2021 - 01/2018
3	Parkinson Disease (Parkinson's Disease) 01/2021 - 05/2019
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 01/2018
2	Poisoning 11/2021 - 01/2016
2	Lymphoma (Lymphomas) 01/2021 - 01/2020
2	Ischemic Stroke 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 02/2017
2	Diarrhea 01/2020 - 01/2018
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2019
2	Necrosis 01/2018 - 10/2014
2	Multiple Sclerosis 01/2018 - 03/2016
2	Brain Neoplasms (Brain Tumor) 04/2015 - 11/2011
2	Lymphatic Metastasis 02/2015 - 06/2013
2	Breast Neoplasms (Breast Cancer) 06/2013 - 11/2011
2	Neuralgia (Stump Neuralgia) 11/2009 - 02/2009
2	Lung Neoplasms (Lung Cancer) 01/2005 - 11/2002
1	Mastitis 04/2022
1	Shock 02/2022
1	AIDS-Related Complex (ARC) 02/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021
1	Central Nervous System Diseases (CNS Diseases) 09/2021
1	Hypertrophic Cicatrix (Hypertrophic Scar) 02/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021
1	Appendicitis 01/2021
1	Amyloid Plaque 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Mycoses (Diseases, Fungus) 07/2020
1	Disease Resistance 07/2020

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
7	IntegrinsIBA 01/2020 - 03/2004
6	InflammasomesIBA 10/2021 - 01/2019
5	IronIBA 03/2016 - 08/2011
5	Monoclonal AntibodiesIBA 11/2009 - 03/2004
4	Long Noncoding RNAIBA 01/2021 - 02/2017
4	Pharmaceutical PreparationsIBA 01/2020 - 12/2016
4	Messenger RNA (mRNA)IBA 01/2019 - 11/2002
3	ferric oxide (iron oxide)IBA 03/2016 - 08/2011
2	LipopolysaccharidesIBA 04/2022 - 01/2020
2	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 10/2021 - 10/2021
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
2	Competitive Endogenous RNAIBA 01/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 07/2020 - 06/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 10/2015
2	2- cyclopentyl- 4- (5- phenyl- 1H- pyrrolo(2,3- b)pyridin- 3- yl)- benzoic acidIBA 04/2018 - 10/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2017 - 06/2017
2	LigandsIBA 01/2017 - 06/2015
2	Androgen Receptors (Androgen Receptor)IBA 06/2015 - 05/2015
2	AndrogensIBA 06/2015 - 05/2015
2	Glucose (Dextrose)FDA LinkGeneric 04/2015 - 01/2005
2	Gadolinium DTPA (Magnevist)FDA Link 04/2015 - 11/2011
2	Ondansetron (Zofran)FDA LinkGeneric 02/2009 - 07/2004
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 02/2009 - 07/2004
2	Serotonin (5 Hydroxytryptamine)IBA 02/2009 - 07/2004
2	Integrin alpha4beta1 (VLA-4)IBA 12/2008 - 12/2008
2	glucose-regulated proteinsIBA 01/2005 - 11/2002
1	EphB2 ReceptorIBA 04/2022
1	ifenprodilIBA 04/2022
1	ElementsIBA 02/2022
1	AlloysIBA 02/2022
1	Organic Chemicals (Chemicals, Organic)IBA 11/2021
1	ethylene dichloride (1,2-dichloroethane)IBA 11/2021
1	indium-bleomycinIBA 10/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2021
1	Apolipoproteins E (ApoE)IBA 09/2021
1	Arginine (L-Arginine)FDA Link 02/2021
1	Glutamic Acid (Glutamate)FDA Link 02/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	Epstein-Barr virus EBV-associated membrane antigenIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	NLR ProteinsIBA 01/2021
1	Miat long non-coding RNAIBA 01/2021
1	SynucleinsIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Lipoxygenase (Lipoxygenase-1)IBA 07/2020
1	AflatoxinsIBA 07/2020
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 07/2020
1	Dextran SulfateIBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Laminin (Merosin)IBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2020 - 11/2011
3	Surgical Instruments (Clip) 02/2009 - 04/2004
2	Radiotherapy 10/2020 - 10/2015
2	Drug Therapy (Chemotherapy) 10/2017 - 06/2017
2	Transplantation 04/2013 - 08/2011
1	Bioelectric Energy Sources 02/2022
1	Appendectomy 01/2021